Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of
lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.